Literature DB >> 24075790

Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes.

Patrícia Ramos1, Agostinho Santos2, Nair Rosas Pinto3, Ricardo Mendes3, Teresa Magalhães4, Agostinho Almeida5.   

Abstract

The link between brain iron homeostasis and neurodegenerative disease has been the subject of extensive research. There is increasing evidence of iron accumulation during ageing, and altered iron levels in some specific brain regions in neurodegenerative disease patients have been reported. Using graphite furnace atomic absorption spectrometry after microwave-assisted acid digestion of the samples, iron levels were determined in 14 different areas of the human brain [frontal cortex, superior and middle temporal, caudate nucleus, putamen, globus pallidus, cingulated gyrus, hippocampus, inferior parietal lobule, visual cortex of the occipital lobe, midbrain, pons (locus coeruleus), medulla and cerebellum (dentate nucleus)] of n=42 adult individuals (71±12 years old, range: 53-101 years old) with no known history or evidence of neurodegenerative, neurological or psychiatric disorders. It was found that the iron distribution in the adult human brain is quite heterogeneous. The highest levels were found in the putamen (mean±SD, range: 855±295μg/g, 304-1628μg/g) and globus pallidus (739±390μg/g, 225-1870μg/g), and the lowest levels were observed in the pons (98±43μg/g, 11-253μg/g) and medulla (56±25μg/g, 13-115μg/g). Globally, iron levels proved to be age-related. The positive correlation between iron levels and age was most significant in the basal ganglia (caudate nucleus, putamen and globus pallidus). Compared with the age-matched control group, altered iron levels were observed in specific brain areas of one Parkinson's disease patient (the basal ganglia) and two Alzheimer's disease patients (the hippocampus).
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Ageing; Human brain; Iron levels; Neurodegenerative diseases; Post-mortem analysis

Mesh:

Substances:

Year:  2013        PMID: 24075790     DOI: 10.1016/j.jtemb.2013.08.001

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  59 in total

1.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

Review 2.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

Review 3.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 4.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 5.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

6.  Multi-element Analysis of Brain Regions from South African Cadavers.

Authors:  Karen Cilliers; Christo J F Muller
Journal:  Biol Trace Elem Res       Date:  2020-05-02       Impact factor: 3.738

7.  Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.

Authors:  Yu-Ting Chen; Wu-Yan Chen; Xiao-Tian Huang; Ye-Chun Xu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

Review 8.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

9.  Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice.

Authors:  Abdel A Belaidi; Adam P Gunn; Bruce X Wong; Scott Ayton; Ambili T Appukuttan; Blaine R Roberts; James A Duce; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Age and sex related differences in subcortical brain iron concentrations among healthy adults.

Authors:  Ninni Persson; Jianlin Wu; Qing Zhang; Ting Liu; Jing Shen; Ruyi Bao; Mingfei Ni; Tian Liu; Yi Wang; Pascal Spincemaille
Journal:  Neuroimage       Date:  2015-07-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.